We use cookies to ensure you get the best experience on our website.

Label & SDS

EPA Label: link

Registration information

  • U.S. EPA Registration number: 11556-100
  • U.S. EPA Status: CANCELLED

Description

'Para-premise Residual Premise Insecticide' is an insecticide and miticide. Its Federal EPA registration number is: 11556-100. It was originally approved by EPA on 26 Mar 1990. Its registration got cancelled on 29 Jul 1999. It has a 'Caution' signal word. It has the following active ingredients: Chlorpyrifos and Resmethrin. It's approved for 7 sites including commercial/industrial/institutional, commercial/institutional/industrial areas, domestic dwellings, pet bedding, pet kennels, and pet living quarters. It is also approved for 22 pests and pest groups including but not limited to ants, boxelder bug, brown dog tick, centipedes, clover mite, cockroaches, crickets, earwigs, fire ant, and firebrat.

Original registration date:

  • 26 Mar 1990

Cancellation date:

  • 29 Jul 1999

Alternative names:

  • PARA-PREMISE RESIDUAL PREMISE INSECTICIDEActive

Registrant:

  • ELANCO US INC.
  • Address:
    2500 Innovation Way
    Greenfield, IN 46140

Active ingredients:

  • Chlorpyrifos 0.5%
  • Resmethrin 0.1%
  • Other ingredients 99.4%

Signal word:

  • Caution

Product type:

  • Insecticide
  • Miticide

Formulation:

  • Emulsifiable Concentrate

Registered target pests:

  • Ants
  • Boxelder bug
  • Brown dog tick
  • Centipedes
  • Clover mite
  • Cockroaches
  • Crickets
  • Earwigs
  • Fire ant
  • Firebrat
  • Fleas
  • Flying moths
  • Gnats
  • House fly
  • Lone star tick
  • Millipedes
  • Mosquitoes
  • Scorpions
  • Silverfish
  • Spider beetles
  • Spiders
  • Waterbugs

Registered target sites:

  • Commercial/industrial/institutional (residual spot treatment-edible)
  • Commercial/institutional/industrial areas (outdoor)
  • Domestic dwellings (indoor)
  • Domestic dwellings (outdoor)
  • Pet bedding
  • Pet kennels (enclosed premise treatment)
  • Pet living quarters (enclosed premise treatment)